Wealthfront Advisers LLC Sells 52,866 Shares of The Clorox Company $CLX

Wealthfront Advisers LLC trimmed its position in The Clorox Company (NYSE:CLX) by 94.4% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 3,115 shares of the company’s stock after selling 52,866 shares during the quarter. Wealthfront Advisers LLC’s holdings in Clorox were worth $314,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently modified their holdings of the company. Center for Financial Planning Inc. acquired a new position in Clorox in the 3rd quarter valued at about $25,000. Vermillion & White Wealth Management Group LLC acquired a new position in Clorox in the 3rd quarter valued at about $25,000. Root Financial Partners LLC acquired a new position in Clorox in the 3rd quarter valued at about $29,000. Darwin Wealth Management LLC acquired a new position in Clorox in the 2nd quarter valued at about $29,000. Finally, Ameriflex Group Inc. grew its stake in Clorox by 1,436.8% in the 3rd quarter. Ameriflex Group Inc. now owns 292 shares of the company’s stock valued at $36,000 after buying an additional 273 shares during the last quarter. 78.53% of the stock is owned by institutional investors.

Clorox Stock Performance

Shares of NYSE:CLX opened at $86.17 on Wednesday. The company’s 50 day moving average price is $107.46 and its two-hundred day moving average price is $108.43. The Clorox Company has a 12-month low of $84.70 and a 12-month high of $138.94. The firm has a market cap of $10.42 billion, a PE ratio of 13.99, a PEG ratio of 0.45 and a beta of 0.59. The company has a quick ratio of 0.65, a current ratio of 0.84 and a debt-to-equity ratio of 27.03.

Clorox (NYSE:CLX) last announced its earnings results on Thursday, April 30th. The company reported $1.64 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.55 by $0.09. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The firm had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.67 billion. During the same quarter in the prior year, the business posted $1.45 EPS. The business’s revenue was up .1% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. Equities research analysts predict that The Clorox Company will post 5.63 earnings per share for the current year.

Clorox Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, May 8th. Investors of record on Wednesday, April 22nd will be given a dividend of $1.24 per share. The ex-dividend date is Wednesday, April 22nd. This represents a $4.96 annualized dividend and a dividend yield of 5.8%. Clorox’s dividend payout ratio (DPR) is currently 80.52%.

Analyst Ratings Changes

A number of research analysts recently commented on CLX shares. BNP Paribas Exane upgraded shares of Clorox from an “underperform” rating to a “neutral” rating in a research note on Wednesday, February 11th. TD Cowen upped their price target on shares of Clorox from $98.00 to $111.00 and gave the company a “hold” rating in a research note on Tuesday, March 31st. Evercore reiterated an “underperform” rating and issued a $110.00 price target on shares of Clorox in a research note on Friday. UBS Group decreased their price target on shares of Clorox from $110.00 to $96.00 and set a “neutral” rating on the stock in a research note on Friday. Finally, Citigroup decreased their target price on shares of Clorox from $110.00 to $97.00 and set a “neutral” rating on the stock in a research report on Friday, May 1st. One analyst has rated the stock with a Buy rating, twelve have assigned a Hold rating and four have issued a Sell rating to the company. According to MarketBeat.com, Clorox presently has an average rating of “Reduce” and a consensus price target of $104.00.

Insider Activity

In other news, Director Pierre R. Breber purchased 5,000 shares of Clorox stock in a transaction that occurred on Tuesday, May 5th. The shares were acquired at an average price of $85.82 per share, for a total transaction of $429,100.00. Following the transaction, the director owned 18,000 shares of the company’s stock, valued at approximately $1,544,760. The trade was a 38.46% increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link. Corporate insiders own 0.63% of the company’s stock.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.